NCT02225067View on ClinicalTrials.gov

Comparison Study Between C13-CAC Breath Test and 24-hour Gastric pH Monitoring

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Gastric Acid-related DiseasesHealthy
Interventions
DRUG

Calcium (13C)Carbonate

Visit 1 and Visit 2, 24-hour gastric pH monitoring and C13-CAC breath test containing 200 mg of Calcium (13C)Carbonate

Trial Locations (1)

532-0003

OPHAC Hospital, Osaka

Sponsors

Collaborators (1)

EPS Corporation
All Listed Sponsors
collaborator

EPS Corporation

OTHER

lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY